U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
128221128221Chloride High Level Of Resuscitation Infusion Chloride High Level Of Resuscitation Infusion Delivered EvaluationActive, not recruitingNo Results AvailableShock|Critical IllnessDrug: Lower chloride fluids (Hartmann's solution and Plasmalyte®)https://ClinicalTrials.gov/show/NCT00885404
128222128222QT Variability Pre and Post CardioversionCompletedNo Results AvailableAtrial Fibrillationhttps://ClinicalTrials.gov/show/NCT00885391
128223128223Efficacy and Safety Study of Saxagliptin + Metformin Immediate Release (IR) Versus Metformin IR Alone in Type 2 Diabetes MellitusCompletedHas ResultsType 2 Diabetes MellitusDrug: Saxagliptin plus metformin IR|Drug: Placebo plus metformin IRhttps://ClinicalTrials.gov/show/NCT00885378
128224128224A Study Comparing the Efficacy and Tolerability of Tobrineb®/Actitob®/Bramitob® Versus TOBI®CompletedHas ResultsCystic FibrosisDrug: tobramycin / Bramitob|Drug: tobramycin / TOBIhttps://ClinicalTrials.gov/show/NCT00885365
128225128225Sitagliptin (MK-0431) vs. Placebo in Patients With Inadequate Glycemic Control on Metformin With Pioglitazone (MK-0431-128)CompletedHas ResultsType 2 Diabetes MellitusDrug: Sitagliptin|Drug: Comparator: Placebo|Drug: Pioglitazone|Drug: Metformin|Drug: Glipizidehttps://ClinicalTrials.gov/show/NCT00885352
128226128226Evaluation of the PillCamâ„¢ Colon Capsule Endoscopy (PCCE) Preparation and ProcedureCompletedNo Results AvailableColonic Diseaseshttps://ClinicalTrials.gov/show/NCT00885339
128227128227N2007-02:Bevacizumab,Cyclophosphamide,& Zoledronic Acid in Patients W/ Recurrent or Refractory High-Risk NeuroblastomaActive, not recruitingNo Results AvailableNeuroblastomaDrug: Bevacizumab|Drug: cyclophosphamide|Drug: zoledronic acidhttps://ClinicalTrials.gov/show/NCT00885326
128228128228Effects of Docosahexaenoic Acid (DHA) on Children With Nonalcoholic Fatty Liver Disease (NAFLD)CompletedNo Results AvailableFatty Liver|Liver Fibrosis|Obesity|Metabolic Syndrome|Nonalcoholic Fatty Liver DiseaseDrug: DHA250|Drug: DHA500|Drug: PLACEBO|Behavioral: Lifestyle interventionhttps://ClinicalTrials.gov/show/NCT00885313
128229128229Cloxacillin as Prevention of Double Lumen Infection in Hemodialysis PatientsCompletedNo Results AvailableDouble Lumen Infection|HemodialysisDrug: cloxacillin|Drug: heparinhttps://ClinicalTrials.gov/show/NCT00885300
128230128230Interactions Between Artemether-lumefantrine and Antiretrovirals in HIV-patients With Uncomplicated Malaria in TanzaniaCompletedNo Results AvailableMalaria, Falciparum|HIV InfectionsDrug: Artemether-lumefantrine (AL)https://ClinicalTrials.gov/show/NCT00885287
128231128231A Randomized Controlled Trial Comparing Two Timing Regimens of Pico-salax for Colon Cleansing Prior to ColonoscopyCompletedNo Results AvailableColonoscopyDrug: Pico-Salax|Drug: Split Dose Pico-Salaxhttps://ClinicalTrials.gov/show/NCT00885274
128232128232The Prevalence of Metabolic Syndrome in Patients Suffering From Chronic PainCompletedNo Results AvailablePain and Metabolic Syndromehttps://ClinicalTrials.gov/show/NCT00885261
128233128233Integrated Positron Emission Tomography - Computed Tomography (PET-CT) in Patients With Pancreatic CancerActive, not recruitingNo Results AvailablePancreatic Cancerhttps://ClinicalTrials.gov/show/NCT00885248
128234128234Evaluation of the PillCamâ„¢ Colon Capsule Endoscopy (PCCE) Preparation and ProcedureCompletedNo Results AvailableBowel Diseaseshttps://ClinicalTrials.gov/show/NCT00885235
128235128235Antidepressant Effect of Deep Brain Stimulation in Parkinson's Disease PatientsCompletedNo Results AvailableParkinson's Disease|Major Depressive DisorderDevice: DBS parameters settinghttps://ClinicalTrials.gov/show/NCT00885222
128236128236Evaluation of the PillCamâ„¢ Colon Capsule Endoscopy (PCCE) Preparation and ProcedureCompletedNo Results AvailableColonic Diseaseshttps://ClinicalTrials.gov/show/NCT00885209
128237128237A Dose Finding Study of AEB071 Assessing Psoriasis Area and Severity Index in Patients With Plaque PsoriasisCompletedNo Results AvailableModerate and Severe Plaque PsoriasisDrug: Placebo|Drug: AEB071https://ClinicalTrials.gov/show/NCT00885196
128238128238Adjuvant Acupuncture Care for Breast Cancer Patients Experiencing Side Effects From ChemotherapyRecruitingNo Results AvailableBreast CancerProcedure: Acupuncture therapyhttps://ClinicalTrials.gov/show/NCT00885183
128239128239A Study to Evaluate the Safety, Tolerability, and Efficacy of Odanacatib (MK0822) in Postmenopausal Women Previously Treated With a Bisphosphonate (0822-042)(COMPLETED)CompletedNo Results AvailableOsteoporosisDrug: odanacatib|Drug: Comparator: Placebo|Dietary Supplement: Vitamin D3|Dietary Supplement: Calciumhttps://ClinicalTrials.gov/show/NCT00885170
128240128240Immunogenicity and Safety of a Fractional Booster Dose of IPV Intradermally Versus Full Dose IntramuscularlyCompletedNo Results AvailablePoliomyelitisBiological: Inactivated types 1, 2, and 3 poliovirus, D antigens|Biological: Inactivated types 1, 2, and 3 poliovirus, D antigenshttps://ClinicalTrials.gov/show/NCT00885157
128241128241Trial on the Acceptability of Modified Lipid Based Nutrient Supplements Among Malawian InfantsCompletedNo Results AvailableMalnutritionDietary Supplement: Nutributter|Dietary Supplement: LNS-20gM|Dietary Supplement: LNS-20gNoM|Dietary Supplement: LNS-10gMhttps://ClinicalTrials.gov/show/NCT00885144
128242128242Effect of Reward on Learning in Motor CortexCompletedNo Results AvailableHealthyhttps://ClinicalTrials.gov/show/NCT00885131
1282431282434 Weeks Treatment With Empagliflozin (BI 10773) in Japanese Type 2 Diabetic Patients (T2DM)CompletedHas ResultsDiabetes Mellitus, Type 2Drug: Placebo (middle dose)|Drug: Placebo|Drug: BI 10773|Drug: BI 10773|Drug: BI 10773|Drug: Placebo (high dose)|Drug: BI 10773|Drug: Placebo (low dose)https://ClinicalTrials.gov/show/NCT00885118
128244128244Evaluation of Responses to Fluzone® in Infants ≥ 6 Months of Age Who Did or Did Not Receive Fluzone® at 2 Months of AgeCompletedHas ResultsInfluenzaBiological: Influenza Virus Vaccine|Biological: Influenza Virus Vaccinehttps://ClinicalTrials.gov/show/NCT00885105
128245128245Single Site Study of the Wettability of Contact Lenses With an Investigational Multi-Purpose Disinfecting Solution vs. a Marketed Multi-Purpose SolutionCompletedHas ResultsContact Lens CareDevice: FID 114675A Multi-Purpose Disinfecting Solution (MPDS)|Device: RepleniSH Multi-Purpose Disinfecting Solution (MPDS) (OPTI-FREE® RepleniSH®)|Device: Senofilcon A contact lens (ACUVUE® Oasys™)|Device: Balafilcon A contact lens (PureVision®)https://ClinicalTrials.gov/show/NCT00885092
128246128246Confirmatory Study of OPC-12759 Ophthalmic SuspensionCompletedHas ResultsDry Eye SyndromesDrug: OPC-12759 Ophthalmic suspension|Drug: Hyalein Mini Ophthalmic solutionhttps://ClinicalTrials.gov/show/NCT00885079
128247128247Gemcitabine, Capecitabine, and Erlotinib in Treating Patients With Advanced Pancreatic CancerCompletedNo Results AvailablePancreatic CancerDrug: capecitabine|Drug: erlotinib hydrochloride|Drug: gemcitabine hydrochloridehttps://ClinicalTrials.gov/show/NCT00885066
128248128248Fish Oil and Inflammation in Overweight SubjectsCompletedNo Results AvailableOverweightDietary Supplement: fish oil|Dietary Supplement: olive oilhttps://ClinicalTrials.gov/show/NCT00885053
128249128249Investigation of Neurofeedback With Real-Time fMRI in Healthy Volunteers and Patients With Hyperkinetic Movement DisordersRecruitingNo Results AvailableMovement Disorder|Tourette Syndrome|Healthy Volunteerhttps://ClinicalTrials.gov/show/NCT00885040
128250128250MEN STUDY (ESTUDIO MEN) Quality of Life in Patients With BPH and Nocturia Before and After Tamsulosin Ocas® TreatmentCompletedNo Results AvailableProstatic Hyperplasiahttps://ClinicalTrials.gov/show/NCT00885027

* Görseller ve İçerik tekif hakkına sahip olabilir